{"data":[{"accessionNo":"0001213900-26-110378","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002002988","issuerName":"Retension Pharmaceuticals, Inc.","ticker":"RTSN","cusip":"76135H100","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-10-13","reportingPerson":"Branden B. Muhl","reportingCik":null,"personType":"HC,IN","sharesOwned":833333,"percentOfClass":10,"filedAt":"2026-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/rtsn"},{"accessionNo":"0001213900-26-110378","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002002988","issuerName":"Retension Pharmaceuticals, Inc.","ticker":"RTSN","cusip":"76135H100","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-10-13","reportingPerson":"B Group Capital LLC","reportingCik":null,"personType":"OO","sharesOwned":833333,"percentOfClass":10,"filedAt":"2026-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/rtsn"},{"accessionNo":"0001213900-26-110378","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002002988","issuerName":"Retension Pharmaceuticals, Inc.","ticker":"RTSN","cusip":"76135H100","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-10-13","reportingPerson":"The B Group, Inc.","reportingCik":null,"personType":"IA,HC","sharesOwned":833333,"percentOfClass":10,"filedAt":"2026-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/rtsn"},{"accessionNo":"0000820434-26-000008","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002002988","issuerName":"Retension Pharmaceuticals, Inc.","ticker":"RTSN","cusip":"76135H100","securityClass":"Common Stock","eventDate":"2026-10-09","reportingPerson":"PVG ASSET MANAGEMENT CORP","reportingCik":null,"personType":"IA,CO,IV","sharesOwned":1002050,"percentOfClass":8.3,"filedAt":"2026-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/rtsn"},{"accessionNo":"0000935836-26-000533","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002002988","issuerName":"Retension Pharmaceuticals, Inc.","ticker":"RTSN","cusip":"76135H100","securityClass":"Common Stock","eventDate":"2026-10-13","reportingPerson":"Laurence W. Lytton","reportingCik":null,"personType":"IN","sharesOwned":617207,"percentOfClass":7.4,"filedAt":"2026-10-15","canonicalUrl":"https://xoomar.com/markets/stocks/rtsn"},{"accessionNo":"0001213900-26-109425","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0002002988","issuerName":"Retension Pharmaceuticals, Inc.","ticker":"RTSN","cusip":"76135H100","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-10-13","reportingPerson":"Eric Keller","reportingCik":"0002156365","personType":"IN","sharesOwned":598598,"percentOfClass":7.07,"filedAt":"2026-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/rtsn"}],"updatedAt":"2026-10-24T09:34:59.929Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/rtsn","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}